Literature DB >> 16599848

Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.

Klaus Jung.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16599848     DOI： 10.1515/CCLM.2006.082

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  1 in total

1.  Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology.

Authors:  M J Li; C X Huang; E Okello; T Yanhong; S Mohamed
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.